Product Information
DARIFENACIN ER 15 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4517 per EA under NDC 65862086230. Its NADAC has been published 460 times since Nov 2, 2016.
FDA first approved this application on Sep 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Darifenacin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862086230
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
DARIFENACIN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206743FDA Approved
9/19/2016
TE Code
AB
On Market Since
9/19/2016
Pharmacological Classes
Price Statistics
The NADAC for DARIFENACIN ER 15 MG TABLET has been published 460 times since Nov 2, 2016, and over the history we have for it it has declined 94.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4517 per EA |
|---|---|
| All-time high | $8.1286 (Feb 15, 2017) |
| All-time low | $0.3150 (Mar 19, 2025) |
| Median price | $2.1287 |
| Average price | $3.0199 |
| Largest weekly change | +137.4% (Jun 23, 2021) |
| Weeks tracked | 460 |
| Tracking since | Nov 2, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-67.1%
5Y
-77.6%
All
-94.3%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DARIFENACIN ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 15 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.4517 per EA (NDC 65862086230), effective Aug 20, 2025.
How has the price of DARIFENACIN ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARIFENACIN ER 15 MG TABLET has declined 94.3%. It has been tracked across 460 weekly CMS publications since Nov 2, 2016.
What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 15 MG TABLET?
Since Nov 2, 2016, the NADAC for DARIFENACIN ER 15 MG TABLET has ranged from a low of $0.3150 (Mar 19, 2025) to a high of $8.1286 (Feb 15, 2017), with a median of $2.1287 per EA.
Are there cheaper alternatives to DARIFENACIN ER 15 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DARIFENACIN ER 15 MG TABLET, is $0.3971 per EA — about 12% below DARIFENACIN ER 15 MG TABLET.
Who manufactures DARIFENACIN ER 15 MG TABLET?
DARIFENACIN ER 15 MG TABLET (NDC 65862086230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.